Study: Over 40% of Deceased Drivers in Crashes Test Positive for THC at Impairment Levels
By
bookofjoe
A respectable bake. You'd come back tomorrow for another.
Summary
A new study analyzing coroner records from Montgomery County, Ohio, found that over 40% of drivers who died in motor vehicle collisions tested positive for active THC in their system, with average blood levels far exceeding those considered to cause impairment. The research, to be presented at the American College of Surgeons Clinical Congress 2025, highlights a significant public health risk that persists despite recreational cannabis legalization.
Key quotes
· 3 pulledover 40% of drivers who died in motor vehicle collisions tested positive for active delta-9-tetrahydrocannabinol (THC) in their system
average blood levels far exceeding those considered to cause impairment
highlights a significant and persistent public health risk that is unchanged by the legalization of recreational cannabis
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·3h ago
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·4h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·6h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·10h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·11h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·11h ago